Figure 4
From: IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice
Treatment with rhIL-18BP increased blood cell counts 4 and 7 days after TBI. Mice received rhIL-18BP (2 mg/kg) or vehicle-injection at 48 h after 9.4 Gy TBI. Total white blood cells (WBC), neutrophil (NEU), lymphocyte (LYM), platelets (PLT) and red blood cells (RBC) were measured in whole blood samples 3, 4 and 7 days after TBI. Results were from two independent experiments (6 mice/group/experiment, N = 12). Means ± SD. Level of increase *p < 0.05; **p < 0.01; rhIL-18BP-treated vs. vehicle-treated.
